The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis.
Arnaiz JA, Rodrigues-Silva C, Mezquida G, Amoretti S, Cuesta MJ, Fraguas D, Lobo A, González-Pinto A, Díaz-Caneja MC, Corripio I, Vieta E, Baeza I, Mané A, García-Rizo C, Bioque M, Saiz J, Bernardo M, Mas S; PEPs group.
Arnaiz JA, et al. Among authors: mane a.
Psychopharmacology (Berl). 2021 Mar;238(3):665-676. doi: 10.1007/s00213-020-05715-5. Epub 2020 Nov 23.
Psychopharmacology (Berl). 2021.
PMID: 33230696